Copyright
©The Author(s) 2021.
World J Clin Cases. Jun 26, 2021; 9(18): 4460-4466
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4460
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4460
Figure 1 Flow chart for determining the treatment strategy for pancreatic ductal adenocarcinoma during COVID-19 pandemic.
1High CA19-9 level, large primary tumor, suspicion of reginonal lymph nodes metastasis excessive weight loss, and extreme pain in accordance with NCCN guideline 2019[22]. PDAC: Pancreatic ductal adenocarcinoma; RPDAC: Resectable PDAC; BRPDAC: borderline resectable PDAC; LAPDAC: Locally advanced PDAC; NAT: Neoadjuvant treantment.
- Citation: Kato H, Asano Y, Arakawa S, Ito M, Kawabe N, Shimura M, Hayashi C, Ochi T, Yasuoka H, Higashiguchi T, Kondo Y, Nagata H, Horiguchi A. Surgery for pancreatic tumors in the midst of COVID-19 pandemic. World J Clin Cases 2021; 9(18): 4460-4466
- URL: https://www.wjgnet.com/2307-8960/full/v9/i18/4460.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i18.4460